Codiak BioSciences Receives $61,000,000 Series B Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=028ca2ba-2f5c-457a-a114-556e39a22a3c - Date
1/26/2016 - Company Name
Codiak BioSciences - Mailing Address
19 Presidential Way Woburn, MA 081801 USA - Company Description
Codiak Biosciences is developing exosomes, natural vesicles that mediate inter-cellular communication, as both a powerful therapeutic modality and an advanced diagnostic system. - Website
http://www.codiakbio.com - Transaction Type
Venture Equity - Transaction Amount
$61,000,000 - Transaction Round
Series B - Proceeds Purposes
With these additional resources we will continue to build our world-class team to realize the broad transformative potential of exosomes for multiple therapeutic and diagnostic uses. Codiak intends to use the proceeds of this round primarily to advance research and clinical development of exosomes for therapeutic and diagnostic purposes. - M&A Terms
- Venture Investor
ARCH Venture Partners - Venture Investor
Flagship Ventures - Venture Investor
Alexandria Venture Investments - Venture Investor
Alaska Permanent Fund - Venture Investor
Fidelity Management & Research Company
